SCHEMBL30700451

SCHEMBL30700451

CS(=O)(=O)c1cccc(CC2CC3(C2)CN(C(=O)N2CC[C@H](C(N)=O)C2)C3)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GRM2 Q14416 2/20 0.36
▸ GRM3 Q14832 2/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ DRD2 P14416 2/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ TNF P01375 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ STAT3 P40763 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CCR5 P51681 1/20 0.35
▸ F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30699883 0.89 CCR5 (0.40) ALDH1A1L3MBTL1SMN1; SMN2TNFLMNA
SCHEMBL30699981 0.88 MGLL (0.37) ALDH1A1NPSR1L3MBTL1SMN1; SMN2TNF
SCHEMBL30775822 0.81 MGLL (0.48) —
SCHEMBL30700066 0.80 MGLL (0.34) ALDH1A1L3MBTL1DRD2HRH1CCR5
SCHEMBL25294377 0.80 GRM2 (0.41) ALDH1A1L3MBTL1GRM2GRM3CHRM4
SCHEMBL30700150 0.80 MGLL (0.35) DRD2DRD3F10
SCHEMBL30700133 0.78 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2CYP2C19
SCHEMBL25326033 0.78 MGLL (0.37) GRM2GRM3DRD2CCR5MMP2
SCHEMBL25324987 0.76 OPRM1 (0.35) GRM2GRM3DRD2DRD3CCR5
SCHEMBL30410079 0.76 MGLL (0.40) GRM2GRM3CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543870-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-04-30 — — EP claimed
CN-119301113-A Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors 豪夫迈·罗氏有限公司 2025-01-10 — — CN claimed
WO-2023247670-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-12-28 — — WO claimed
CN-119301113-A Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors 豪夫迈·罗氏有限公司 2025-01-10 — — CN disclosed
WO-2023247670-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-12-28 — — WO disclosed
Send feedback